Compare Stocks: MOBI, BVS, AORT, and IRMD

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
AORT Artivion	$22.99 +1.6%	$26.20	$19.16 ▼ $48.25	$1.12B	1.25	604,933 shs	201,566 shs
BVS Bioventus	$14.00 +1.4%	$13.51	$6.37 ▼ $15.89	$1.18B	0.65	532,523 shs	258,076 shs
IRMD iRadimed	$86.65 +1.0%	$88.06	$67.84 ▼ $107.90	$1.11B	0.89	110,477 shs	54,875 shs
MOBI Mobia Medical	$8.88 -2.0%	$11.09	$8.45 ▼ $15.29	$295.62M	N/A	174,322 shs	276,178 shs

The 7 Hottest IPO Stories of 2026

MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
AORT Artivion	0.00%	-2.92%	-15.21%	+0.99%	-44.61%
BVS Bioventus	0.00%	+6.97%	-0.22%	+41.21%	+107.36%
IRMD iRadimed	0.00%	+4.43%	-1.50%	-8.83%	+22.04%
MOBI Mobia Medical	0.00%	-14.04%	-20.11%	-37.00%	+905,999,900.00%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
AORT Artivion	$22.99 +1.6%	$26.20	$19.16 ▼ $48.25	$1.12B	1.25	604,933 shs	201,566 shs
BVS Bioventus	$14.00 +1.4%	$13.51	$6.37 ▼ $15.89	$1.18B	0.65	532,523 shs	258,076 shs
IRMD iRadimed	$86.65 +1.0%	$88.06	$67.84 ▼ $107.90	$1.11B	0.89	110,477 shs	54,875 shs
MOBI Mobia Medical	$8.88 -2.0%	$11.09	$8.45 ▼ $15.29	$295.62M	N/A	174,322 shs	276,178 shs

The 7 Hottest IPO Stories of 2026

MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
AORT Artivion	0.00%	-2.92%	-15.21%	+0.99%	-44.61%
BVS Bioventus	0.00%	+6.97%	-0.22%	+41.21%	+107.36%
IRMD iRadimed	0.00%	+4.43%	-1.50%	-8.83%	+22.04%
MOBI Mobia Medical	0.00%	-14.04%	-20.11%	-37.00%	+905,999,900.00%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
AORT Artivion	2.75	Moderate Buy	$44.83	95.04% Upside
BVS Bioventus	2.83	Moderate Buy	$16.80	20.00% Upside
IRMD iRadimed	2.83	Moderate Buy	$120.00	38.50% Upside
MOBI Mobia Medical	2.57	Moderate Buy	$20.75	133.67% Upside

Current Analyst Ratings Breakdown

Latest MOBI, BVS, AORT, and IRMD Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
9/22/2026	IRMD iRadimed	Needham & Company LLC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Initiated Coverage	Hold
9/9/2026	IRMD iRadimed	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Hold (C+) ➝ Buy (B-)
8/18/2026	AORT Artivion	Canaccord Genuity Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Buy	$39.00 ➝ $40.00
8/17/2026	BVS Bioventus	Canaccord Genuity Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Buy	$15.00 ➝ $19.00
8/17/2026	BVS Bioventus	Cantor Fitzgerald Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Overweight	$15.00
8/12/2026	MOBI Mobia Medical	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Initiated Coverage	Sell (E-)
8/12/2026	MOBI Mobia Medical	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Overweight	$15.00 ➝ $17.00
8/12/2026	MOBI Mobia Medical	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Buy	$19.00
8/11/2026	AORT Artivion	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Sell (D+) ➝ Sell (D-)
8/7/2026	AORT Artivion	Canaccord Genuity Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Set Price Target		$39.00
8/6/2026	BVS Bioventus	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Hold (C) ➝ Hold (C+)

(Data available from 9/28/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
AORT Artivion	$441.33M	2.54	$1.12 per share	20.54	$9.46 per share	2.43
BVS Bioventus	$568.09M	2.07	$1.29 per share	10.83	$2.76 per share	5.07
IRMD iRadimed	$83.81M	13.22	$1.88 per share	46.14	$7.44 per share	11.65
MOBI Mobia Medical	$32.04M	9.23	N/A	N/A	N/A	∞

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
AORT Artivion	$9.77M	-$0.07	N/A	29.85	N/A	-0.67%	6.07%	2.93%	11/5/2026 (Estimated)
BVS Bioventus	$22.73M	$0.77	18.18	15.73	1.76	9.36%	28.08%	9.82%	N/A
IRMD iRadimed	$22.48M	$1.79	48.41	N/A	N/A	26.70%	23.45%	20.36%	11/2/2026 (Estimated)
MOBI Mobia Medical	-$46.50M	-$20.18	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Latest MOBI, BVS, AORT, and IRMD Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/11/2026	Q2 2026	MOBI Mobia Medical	-$0.83	-$1.10	-$0.27	-$1.10	N/A	$13.51 million
8/6/2026	Q2 2026	AORT Artivion	$0.0025	$0.13	+$0.1275	-$0.28	$119.99 million	$125.76 million
8/5/2026	Q2 2026	BVS Bioventus	$0.22	$0.22	N/A	$0.47	N/A	$153.21 million
7/31/2026	Q2 2026	IRMD iRadimed	$0.44	$0.46	+$0.02	$0.41	$20.35 million	$20.47 million

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
AORT Artivion	N/A	N/A	N/A	N/A	N/A
BVS Bioventus	N/A	N/A	N/A	N/A	N/A
IRMD iRadimed	$0.80	0.92%	N/A	44.69%	1 Years
MOBI Mobia Medical	N/A	N/A	N/A	N/A	N/A

Latest MOBI, BVS, AORT, and IRMD Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
7/30/2026	IRMD iRadimed	quarterly	$0.20	0.92%	8/14/2026	8/14/2026	8/28/2026

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
AORT Artivion	0.82	3.47	2.51
BVS Bioventus	0.83	1.69	1.17
IRMD iRadimed	N/A	9.46	8.13
MOBI Mobia Medical	0.04	13.28	12.80

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
AORT Artivion	86.37%
BVS Bioventus	62.94%
IRMD iRadimed	92.34%
MOBI Mobia Medical	N/A

Insider Ownership

Company	Insider Ownership
AORT Artivion	6.30%
BVS Bioventus	33.50%
IRMD iRadimed	34.60%
MOBI Mobia Medical	N/A

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
AORT Artivion	1,800	48.76 million	45.68 million	Optionable
BVS Bioventus	950	84.09 million	55.92 million	N/A
IRMD iRadimed	166	12.79 million	8.36 million	Optionable
MOBI Mobia Medical	167	33.29 million	N/A	N/A

MOBI, BVS, AORT, and IRMD Headlines

Recent News About These Companies

Mobia Medical Inc.

September 26 at 5:39 AM | money.usnews.com

Reza Zadno Joins Mobia Medical’s Board of Directors

September 24, 2026 | mpo-mag.comM

Mobia Medical Stock Price History

September 16, 2026 | investing.com

Mobia Medical (NASDAQ:MOBI) Insider Chase Leavitt Purchases 2,000 Shares of Stock

September 16, 2026 | insidertrades.com

Mobia Medical (NASDAQ:MOBI) Insider Purchases $20,600.00 in Stock

September 15, 2026 | marketbeat.com

Mobia Medical, Inc. (NASDAQ:MOBI) Given Consensus Recommendation of "Moderate Buy" by Brokerages

September 10, 2026 | marketbeat.com

Mobia Medical Announces Paired VNS Added To Updated AHA Stroke Recovery Guidelines

August 28, 2026 | rttnews.com

Mobia Medical Announces Addition of Paired VNS to Updated AHA Stroke Guidelines

August 28, 2026 | globenewswire.com

Insider Buying: Mobia Medical (NASDAQ:MOBI) Director Buys $198,442.87 in Stock

August 21, 2026 | insidertrades.com

Mobia Medical (MOBI) Q2 2026 Earnings Call Transcript

August 18, 2026 | finance.yahoo.com

Mobia Medical (NASDAQ:MOBI) Director Purchases 15,821 Shares

August 18, 2026 | insidertrades.com

Mobia Medical Signals Fast Growth in Earnings Call

August 16, 2026 | tipranks.com

Mobia Medical, Inc.: Mobia Medical Reports Second Quarter 2026 Financial Results

August 12, 2026 | finanznachrichten.de

Mobia Medical Inc (MOBI) (Q2 2026) Earnings Call Highlights: Revenue Surges 102% as IPO Fuels ...

August 12, 2026 | finance.yahoo.com

Mobia Medical forecasts $54M-$56M 2026 revenue, citing 69%-75% growth target

August 11, 2026 | seekingalpha.com

Mobia Medical, Inc. (MOBI) Q2 2026 Earnings Call Transcript

August 11, 2026 | seekingalpha.com

Mobia Medical: Q2 Earnings Snapshot

August 11, 2026 | finance.yahoo.com

Mobia Medical Reports Second Quarter 2026 Financial Results

August 11, 2026 | globenewswire.com

Mobia Medical Appoints Myriam Curet, M.D., to its Board of Directors

August 3, 2026 | markets.businessinsider.com

Mobia Medical to Report Second Quarter 2026 Financial Results on August 11, 2026

July 21, 2026 | globenewswire.com

Mobia Medical Inc (MOBI)

July 15, 2026 | investing.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

MOBI, BVS, AORT, and IRMD Company Descriptions

Artivion NYSE:AORT

$22.99 +0.36 (+1.58%)

As of 03:06 PM Eastern

Artivion, Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide. The company provides BioGlue, a polymer consisting of bovine blood protein and an agent for cross-linking proteins for cardiac, vascular, neurologic, and pulmonary procedures; cardiac preservation services; PhotoFix, a bovine pericardial patch; and aortic arch stent grafts including E-vita Open Plus and E-vita Open Neo. It offers E-xtra design engineering systems for the treatment of aortic vascular diseases; E-nside, an off-the-shelf stent graft for the treatment of thoraco-abdominal disease; E-vita THORACIC 3G for the endovascular treatment of thoracic aortic aneurysms; E-ventus BX, a balloon-expandable peripheral stent graft for the endovascular treatment of renal and pelvic arteries; E-liac to treat aneurysmal iliac arteries, and aneurysmal iliac side branches; and E-tegra, a stent graft system for the treatment of infrarenal abdominal aortic aneurysms. In addition, the company offers synthetic vascular grafts for use in open aortic and peripheral vascular surgical procedures; PerClot, an absorbable powdered hemostat for use in surgical procedures; cardiac laser therapy products for angina treatment; CryoVein femoral vein and CryoArtery femoral artery vascular preservation services; On-X prosthetic aortic and mitral heart valves and the On-X ascending aortic prosthesis; CarbonAid CO2 diffusion catheters and Chord-X ePTFE sutures for mitral chordal replacement; and ascyrus medical dissection stents, as well as pyrolytic carbon coating services to medical device manufacturers. It serves physicians, hospitals, and other healthcare facilities, as well as cardiac, vascular, thoracic, and general surgeons. The company was formerly known as CryoLife, Inc. and changed its name to Artivion, Inc. in January 2022. Artivion, Inc. was incorporated in 1984 and is headquartered in Kennesaw, Georgia.

Bioventus NASDAQ:BVS

$14.00 +0.19 (+1.38%)

As of 03:06 PM Eastern

Bioventus Inc. a medical device company, focuses on developing and commercializing clinically treatments that engage and enhance the body's natural healing process in the United States and internationally. The company's portfolio of products includes pain treatments, which comprise non-surgical joint pain injection therapies, as well as peripheral nerve stimulation products. Its surgical solutions include bone graft substitutes to fuse and grow bones, enhance results following spinal and other orthopedic surgeries; and ultrasonic medical devices for the use in precise bone sculpting, remove tumors, and tissue debridement. The company's restorative therapies comprise an ultrasonic bone healing system for fracture care; skin allografts; and products that are used to support healing of chronic wounds, as well as advanced rehabilitation devices designed to help patients regain leg or hand function. It serves physicians spanning the orthopedic continuum, including sports medicine, total joint reconstruction, hand and upper extremities, foot and ankle, podiatric surgery, trauma, spine, and neurosurgery in the physician's office or clinic, ambulatory surgical centers, or in the hospital setting. The company was founded in 2011 and is headquartered in Durham, North Carolina.

iRadimed NASDAQ:IRMD

$86.64 +0.89 (+1.03%)

As of 03:06 PM Eastern

IRadimed Corp. engages in the development, manufacture, marketing, and distribution of Magnetic Resonance Imaging compatible medical devices. It also provides a non-magnetic Intravenous infusion pump system that is specifically designed for use during MRI procedures. The company was founded by Roger Susi in July 1992 and is headquartered in Winter Springs, FL.

Mobia Medical NASDAQ:MOBI

$8.88 -0.18 (-1.99%)

As of 02:51 PM Eastern

Mobia Medical Inc. is a commercial-stage medical device company redefining stroke recovery for survivors living with life-altering motor impairments. Mobia Medical Inc. is based in AUSTIN, Texas.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest MOBI, BVS, AORT, and IRMD Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest MOBI, BVS, AORT, and IRMD Earnings

Compare Dividends

Latest MOBI, BVS, AORT, and IRMD Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

MOBI, BVS, AORT, and IRMD Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

MOBI, BVS, AORT, and IRMD Company Descriptions

Artivion NYSE:AORT

Bioventus NASDAQ:BVS

iRadimed NASDAQ:IRMD

Mobia Medical NASDAQ:MOBI

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools